Treating Hepatitis C Virus Infection in Jails as an Offset to Declines in Treatment Activity in the Community, New York City, NY, 2014–2020

Introduction: There are scant data on implementation of large-scale direct-acting antiviral treatment for hepatitis C virus in jails in the U.S. New York City Health + Hospitals/Correctional Health Services aimed to scale up hepatitis C virus treatment in the New York City jail system. This study de...

Full description

Bibliographic Details
Main Authors: Justin Chan, MD, Matthew J. Akiyama, MD, Emily Julian, RN, Rodrigue Joseph, MD, Wendy McGahee, MD, Zachary Rosner, MD, Patricia Yang, DrPH, Ross MacDonald, MD
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:AJPM Focus
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S277306542400004X
_version_ 1827367064651694080
author Justin Chan, MD
Matthew J. Akiyama, MD
Emily Julian, RN
Rodrigue Joseph, MD
Wendy McGahee, MD
Zachary Rosner, MD
Patricia Yang, DrPH
Ross MacDonald, MD
author_facet Justin Chan, MD
Matthew J. Akiyama, MD
Emily Julian, RN
Rodrigue Joseph, MD
Wendy McGahee, MD
Zachary Rosner, MD
Patricia Yang, DrPH
Ross MacDonald, MD
author_sort Justin Chan, MD
collection DOAJ
description Introduction: There are scant data on implementation of large-scale direct-acting antiviral treatment for hepatitis C virus in jails in the U.S. New York City Health + Hospitals/Correctional Health Services aimed to scale up hepatitis C virus treatment in the New York City jail system. This study describes the trends in annual hepatitis C virus treatment in New York City jails compared with those in Medicaid-funded treatment in the New York City community from 2014 to 2020. Methods: In this observational study, we extracted annual counts of direct-acting antiviral prescriptions for hepatitis C virus for those (1) in the New York City community who were covered by Medicaid and (2) those detained in New York City jails for 2014–2020. Data sources were New York City Department of Health and Mental Hygiene annual reports and Correctional Health Services treatment records, respectively. We used linear regression analysis to test for significant trends in annual treatment in these 2 cohorts during 2015–2019. Results: From 2015 to 2019, treatments started in New York City jails increased annually (p=0.001), whereas Medicaid-funded prescriptions in the New York City community declined since a peak in 2015 (p<0.001). In 2019, New York City jail-based treatment initiations totaled the equivalent of 10% of treatment covered by Medicaid in New York City, up from 0.3% in 2015. Conclusions: Scale up of jail-based hepatitis C virus treatment is an important strategy to offset declines observed in the community. Addressing barriers to care in jail, such as improving testing, linkage to care, and affordability of direct-acting antivirals for jail-based health services, can help sustain high levels of treatment in U.S. jails and other carceral facilities.
first_indexed 2024-03-08T09:00:08Z
format Article
id doaj.art-055bc3a2c68c4fef90ba0c9b2d5e04c2
institution Directory Open Access Journal
issn 2773-0654
language English
last_indexed 2024-03-08T09:00:08Z
publishDate 2024-04-01
publisher Elsevier
record_format Article
series AJPM Focus
spelling doaj.art-055bc3a2c68c4fef90ba0c9b2d5e04c22024-02-01T06:35:52ZengElsevierAJPM Focus2773-06542024-04-0132100185Treating Hepatitis C Virus Infection in Jails as an Offset to Declines in Treatment Activity in the Community, New York City, NY, 2014–2020Justin Chan, MD0Matthew J. Akiyama, MD1Emily Julian, RN2Rodrigue Joseph, MD3Wendy McGahee, MD4Zachary Rosner, MD5Patricia Yang, DrPH6Ross MacDonald, MD7NYC Health + Hospitals/Bellevue, New York, New York; Department of Medicine, NYU Grossman School of Medicine, New York, New York; Address correspondence to: Justin Chan, MD MPH, NYC Health + Hospitals/Bellevue, 462 First Avenue, HB 6W57, New York NY 10016.NYC Health + Hospitals/Correctional Health Services, NYC Health + Hospitals, New York, New York; Montefiore Einstein Department of Medicine, Albert Einstein College of Medicine, Bronx, New YorkNYC Health + Hospitals/Correctional Health Services, NYC Health + Hospitals, New York, New YorkNYC Health + Hospitals/Correctional Health Services, NYC Health + Hospitals, New York, New YorkNYC Health + Hospitals/Correctional Health Services, NYC Health + Hospitals, New York, New YorkDepartment of Medicine, NYU Grossman School of Medicine, New York, New York; NYC Health + Hospitals/Correctional Health Services, NYC Health + Hospitals, New York, New YorkNYC Health + Hospitals/Correctional Health Services, NYC Health + Hospitals, New York, New YorkDepartment of Medicine, NYU Grossman School of Medicine, New York, New York; NYC Health + Hospitals/Woodhull, NYC Health + Hospitals, New York, New YorkIntroduction: There are scant data on implementation of large-scale direct-acting antiviral treatment for hepatitis C virus in jails in the U.S. New York City Health + Hospitals/Correctional Health Services aimed to scale up hepatitis C virus treatment in the New York City jail system. This study describes the trends in annual hepatitis C virus treatment in New York City jails compared with those in Medicaid-funded treatment in the New York City community from 2014 to 2020. Methods: In this observational study, we extracted annual counts of direct-acting antiviral prescriptions for hepatitis C virus for those (1) in the New York City community who were covered by Medicaid and (2) those detained in New York City jails for 2014–2020. Data sources were New York City Department of Health and Mental Hygiene annual reports and Correctional Health Services treatment records, respectively. We used linear regression analysis to test for significant trends in annual treatment in these 2 cohorts during 2015–2019. Results: From 2015 to 2019, treatments started in New York City jails increased annually (p=0.001), whereas Medicaid-funded prescriptions in the New York City community declined since a peak in 2015 (p<0.001). In 2019, New York City jail-based treatment initiations totaled the equivalent of 10% of treatment covered by Medicaid in New York City, up from 0.3% in 2015. Conclusions: Scale up of jail-based hepatitis C virus treatment is an important strategy to offset declines observed in the community. Addressing barriers to care in jail, such as improving testing, linkage to care, and affordability of direct-acting antivirals for jail-based health services, can help sustain high levels of treatment in U.S. jails and other carceral facilities.http://www.sciencedirect.com/science/article/pii/S277306542400004XHepatitis Cdirect-acting antiviraljails
spellingShingle Justin Chan, MD
Matthew J. Akiyama, MD
Emily Julian, RN
Rodrigue Joseph, MD
Wendy McGahee, MD
Zachary Rosner, MD
Patricia Yang, DrPH
Ross MacDonald, MD
Treating Hepatitis C Virus Infection in Jails as an Offset to Declines in Treatment Activity in the Community, New York City, NY, 2014–2020
AJPM Focus
Hepatitis C
direct-acting antiviral
jails
title Treating Hepatitis C Virus Infection in Jails as an Offset to Declines in Treatment Activity in the Community, New York City, NY, 2014–2020
title_full Treating Hepatitis C Virus Infection in Jails as an Offset to Declines in Treatment Activity in the Community, New York City, NY, 2014–2020
title_fullStr Treating Hepatitis C Virus Infection in Jails as an Offset to Declines in Treatment Activity in the Community, New York City, NY, 2014–2020
title_full_unstemmed Treating Hepatitis C Virus Infection in Jails as an Offset to Declines in Treatment Activity in the Community, New York City, NY, 2014–2020
title_short Treating Hepatitis C Virus Infection in Jails as an Offset to Declines in Treatment Activity in the Community, New York City, NY, 2014–2020
title_sort treating hepatitis c virus infection in jails as an offset to declines in treatment activity in the community new york city ny 2014 2020
topic Hepatitis C
direct-acting antiviral
jails
url http://www.sciencedirect.com/science/article/pii/S277306542400004X
work_keys_str_mv AT justinchanmd treatinghepatitiscvirusinfectioninjailsasanoffsettodeclinesintreatmentactivityinthecommunitynewyorkcityny20142020
AT matthewjakiyamamd treatinghepatitiscvirusinfectioninjailsasanoffsettodeclinesintreatmentactivityinthecommunitynewyorkcityny20142020
AT emilyjulianrn treatinghepatitiscvirusinfectioninjailsasanoffsettodeclinesintreatmentactivityinthecommunitynewyorkcityny20142020
AT rodriguejosephmd treatinghepatitiscvirusinfectioninjailsasanoffsettodeclinesintreatmentactivityinthecommunitynewyorkcityny20142020
AT wendymcgaheemd treatinghepatitiscvirusinfectioninjailsasanoffsettodeclinesintreatmentactivityinthecommunitynewyorkcityny20142020
AT zacharyrosnermd treatinghepatitiscvirusinfectioninjailsasanoffsettodeclinesintreatmentactivityinthecommunitynewyorkcityny20142020
AT patriciayangdrph treatinghepatitiscvirusinfectioninjailsasanoffsettodeclinesintreatmentactivityinthecommunitynewyorkcityny20142020
AT rossmacdonaldmd treatinghepatitiscvirusinfectioninjailsasanoffsettodeclinesintreatmentactivityinthecommunitynewyorkcityny20142020